IL17RC

Across TCGA pan-cancer cohorts, IL17RC Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated IL17RC data layer compared with 22 for mass-spec protein and 1 for mass-spec protein.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher IL17RC Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated IL17RC expression acts as an unfavorable survival marker.

KIRC and SKCM are the cancer types where IL17RC Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Median	All	0.144	0.655	.029	12	view →
SKCM	OS	Median	All	0.194	0.784	<.001	12	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

IL17RC–KIRC (OS)

Open the KIRC breakdown →